Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : N::A source : Mindmed.co save search
MindMed Reports Third Quarter 2023 Financial Results and Business Highlights
Published: 2023-11-02 (Crawled : 21:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 2.22%
H: 13.04%
C: 11.96%
business financial results
MindMed to Host Conference Call and Webcast to Discuss Third Quarter 2023 Financial Results and Provide Business Update
Published: 2023-10-26 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.77%
H: 2.33%
C: 0.39%
conference business update financial results
MindMed Completes Enrollment of Phase 2a Trial of MM-120 in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
Published: 2023-10-24 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 2.28%
H: 3.72%
C: 0.74%
mm-120 trial
MindMed to Present Data on the Preclinical Activity of MM-402 at the 36th Annual European College of Neuropsychopharmacology (ECNP) Congress
Published: 2023-10-03 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.65%
H: 0.0%
C: -2.3%
mm-402 congress preclinical
MindMed to Participate in the TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit
Published: 2023-09-14 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 0.74%
H: 6.37%
C: 5.64%
MindMed Completes Enrollment of Phase 2b Trial of MM-120 in Generalized Anxiety Disorder (GAD)
Published: 2023-09-12 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 0.7%
H: 3.92%
C: -2.76%
mm-120 trial
MindMed to Participate at September Investor Conferences
Published: 2023-08-28 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 1.32%
H: 3.12%
C: -1.04%
MindMed Secures $50.0 Million Credit Facility with K2 HealthVentures
Published: 2023-08-14 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 0.23%
H: 5.85%
C: 4.68%
MindMed Reports Second Quarter 2023 Financial Results and Business Highlights
Published: 2023-08-03 (Crawled : 21:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.85%
H: 2.78%
C: -6.85%
business financial results
MindMed Announces Exclusive License Agreement With Catalent for Its Patented Zydis® Fast-Dissolve Technology for Use with MM-120
Published: 2023-08-03 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 0.22%
H: 4.72%
C: 2.39%
mm-120 zydis license technology agreement
MindMed to Participate in the H.C. Wainwright 4th Annual Neuropsychiatry Virtual Conference
Published: 2023-06-22 (Crawled : 13:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.83%
H: 0.56%
C: -2.52%
conference
MindMed Announces Election of All Six Company Nominees at Annual Meeting
Published: 2023-06-21 (Crawled : 17:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -1.11%
H: 2.24%
C: 0.84%
six meeting
MindMed Provides Overview of Clinical Progress and Corporate Updates at Investor Day
Published: 2023-06-20 (Crawled : 13:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -1.06%
H: 0.0%
C: -3.22%
day
MindMed Adjourns Annual General Meeting of Shareholders
Published: 2023-06-15 (Crawled : 15:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.55%
H: 3.33%
C: 3.06%
meeting
MindMed Urges Shareholders to Vote TODAY for Company Nominees Ahead of June 13th Deadline
Published: 2023-06-09 (Crawled : 13:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 1.06%
H: 1.57%
C: -4.19%
deadline today
Leading Proxy Advisory Firm Glass Lewis Recommends MindMed Shareholders Vote FOR All Six Company Nominees
Published: 2023-06-08 (Crawled : 16:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.55%
H: 6.67%
C: 5.0%
six glass
MindMed to Host Investor Day June 2023
Published: 2023-06-07 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.28%
H: 7.0%
C: 1.4%
day
Leading Proxy Advisory Firm ISS Recommends MindMed Shareholders Vote FOR All Six Company Nominees
Published: 2023-06-05 (Crawled : 12:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: 1.01%
H: 3.44%
C: 0.86%
six
MindMed to Participate at Upcoming Investor Conferences
Published: 2023-06-01 (Crawled : 11:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -0.56%
H: 0.99%
C: 0.85%
MindMed Releases Investor Presentation Highlighting How the Company is Unlocking the Power of Psychedelics for Patients and Shareholders
Published: 2023-05-25 (Crawled : 21:00) - mindmed.co
MNMD | $8.46 -4.62% -4.97% 780K
|
n/a
|
| O: -1.19%
H: 8.16%
C: 6.8%
presentation
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4253 179.25% 64.77% 210M
|
Consumer Services
BOF | $2.08 77.78% 41.21% 110M
|
ILAG | $0.54 12.27% 40.62% 3.7M
|
LICN | $0.999 78.39% 40.49% 15M
|
AMST | $3.4 70.0% 39.58% 70M
|
Technology Services
MTC | $3.6 60.71% 38.04% 9.1M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.458 14.5% 30.92% 91K
|
Health Services
MULN | News | $3.77 38.1% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.